This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why You Should Add Cboe Global (CBOE) Stock to Your Portfolio
by Zacks Equity Research
Cboe Global (CBOE) is set to grow on its organic growth, strategic acquisitions and effective capital deployment.
Nasdaq Partners With Stifel for Alternative Trading System
by Zacks Equity Research
Nasdaq (NDAQ) and Stifel sign market technology agreement to offer unique liquidity to clients.
The VIX is not really a "Fear Gauge"
by David Borun
Though fear is one component of options prices, there's much more to it.
Cboe Global (CBOE) to Acquire MATCHNow, Foray Into Canada
by Zacks Equity Research
Cboe Global's (CBOE) pending buyout of MATCHNow is likely to broaden its North American equities business.
Why You Should Buy Intercontinental Exchange (ICE) Stock
by Zacks Equity Research
Intercontinental Exchange (ICE) is poised to grow over the long term given its operational excellence and solid capital position.
Intercontinental Exchange Offers $2.5 Billion Senior Notes
by Zacks Equity Research
Intercontinental Exchange (ICE) displays prudence by issuing senior notes amid a low interest rate environment to procure funds.
Here's Why You Should Add Nasdaq (NDAQ) to Your Portfolio
by Zacks Equity Research
Nasdaq (NDAQ) is poised to grow over the long term given its operational excellence and growth initiatives.
MarketAxess Banks on High Revenues & Strong Capital Position
by Zacks Equity Research
MarketAxess (MKTX) is poised to benefit from strong revenues, robust trading volumes and sound liquidity position.
As the VIX Falls, It's Time To Consider Buying Options
by David Borun
With the VIX back at 30% even as uncertainty lurks, the Straddle is looking like a good bet.
Cboe Global (CBOE) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Cboe Global's (CBOE) Q1 results reflect increased trading activity, decline in expenses and operational efficiencies.
CBOE Holdings (CBOE) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CBOE (CBOE) delivered earnings and revenue surprises of 7.14% and 1.07%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Cboe Global (CBOE) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Cboe Global's (CBOE) first-quarter 2020 performance is likely to have benefited from acquisition and lower expenses, offset by lower transaction fees.
CBOE Holdings (CBOE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CBOE (CBOE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nasdaq's (NDAQ) Q1 results reflect growth in Market Services, Corporate Services, Information Services and Market Technology segments.
Stocks Continue to Rally as Coronavirus Cases Level Off
by David Borun
Fiscal and monetary stimuli help push US equities higher amid signs the curve is flattening.
Will Cboe Global Markets Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Cboe Global Markets
Zacks.com featured highlights include: Regency Centers, ResMed, Synopsys, Cboe Global Markets and The Southern Company
by Zacks Equity Research
Zacks.com featured highlights include: Regency Centers, ResMed, Synopsys, Cboe Global Markets and The Southern Company
Sales Growth Makes These 5 Stocks Good Bets Amid Coronavirus Woes
by Swayta Shah
Amid coronavirus-related market mayhem and economic slowdown, sales growth can be considered by investors as a reliable metric for selecting profitable stocks.
CME Group's (CME) Volumes for March & Q1 Solid, Increase Y/Y
by Zacks Equity Research
CME Group's (CME) average daily volume for March and first-quarter 2020 increases on the back of better contribution by all six product lines.
Cboe Global's (CBOE) March Average Daily Volume Increases Y/Y
by Zacks Equity Research
Cboe Global's (CBOE) Options, Futures U.S. Equities, European Equities and Global Forex volume reflect y/y increases in March.
3 Stocks Immune to the Coronavirus Downturn to Buy Right Now
by Benjamin Rains
Today's episode of Full Court Finance here at Zacks quickly dives into why Wall Street seems optimistic on Monday. Despite the positivity, investors should still be on the hunt for stocks that appear immune to the broader coronavirus fallout...
Intercontinental Exchanges (ICE) March Volume Improves Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) March volume indicates improved Financial ADV, Commodities ADV and Energy ADV.
Buy Nasdaq (NDAQ) Stock for Safety Amid Coronavirus Market Volatility?
by Benjamin Rains
Nasdaq (NDAQ) shares have surged roughly 30% in the last two weeks and its earnings revisions have climbed amid the broader coronavirus economic downturn...
MarketAxess (MKTX) Reports Solid March Volume Statistics
by Zacks Equity Research
MarketAxess (MKTX) reports impressive volume data for March 2020.
Why the Earnings Surprise Streak Could Continue for CBOE (CBOE)
by Zacks Equity Research
CBOE (CBOE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.